FindTrial
Sign In

Adhibition for Clopidogrel loading dose in acute ischemic stroke

Adhibition for Clopidogrel loading dose in acute ischemic stroke - CLD in stroke

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000021840
Enrollment
50
Registered
2016-04-12
Start date
2016-04-01
Completion date
Unknown
Last updated
2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ischemic stroke

Interventions

Clopidogrel 300 mg

Sponsors

Department of Neurology, Tokyo Women's Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria: pancytopenia severe liver dysfunction and/or renal dysfunction hemorrhagic transformation in brain CT or MRI active hemorrhagic lesion

Design outcomes

Primary

MeasureTime frame
Hemorrhagic complication and recurrent stroke of the start of the onset of ischemic stroke within three weeks.—

Countries

Japan

Contacts

Public ContactSono Toi

Tokyo Women's Medical University Department of Neurology

stoi@nij.twmu.ac.jp+81-3-3353-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026